Company Overview

Canaan Partners is a venture capital firm specializing in all stages of development, seed financings, start-ups, and early stage investments, typically Series A and B financings. It typically invests in technology and healthcare sectors. In technology, it focuses on clean technology; electronics and computer hardware; digital media; enterprise software and services; and communications and mobility. In the healthcare sector, it focuses on biopharmaceuticals, drug discovery, healthcare infrastructure, medical devices, and diagnostics. Within digital media and communications, the firm invests in infrastructure technologies through semiconductors, systems, devices, and applications in next gener...

Canaan Partners is a venture capital firm specializing in all stages of development, seed financings, start-ups, and early stage investments, typically Series A and B financings. It typically invests in technology and healthcare sectors. In technology, it focuses on clean technology; electronics and computer hardware; digital media; enterprise software and services; and communications and mobility. In the healthcare sector, it focuses on biopharmaceuticals, drug discovery, healthcare infrastructure, medical devices, and diagnostics. Within digital media and communications, the firm invests in infrastructure technologies through semiconductors, systems, devices, and applications in next generation advertising technologies, online content communities, and networking and communication infrastructure. In clean technology, the firm invests in early stage and mid-stage investments in technology-driven companies in sectors such as energy efficiency; energy storage; alternative power generation; and carbon sequestration and clean coal. In biopharmaceuticals, it seeks to invest in high-growth pharmaceutical companies developing new vaccines and therapeutics to combat infectious diseases, oncology, Ophthalmology, antifungals, antivirals, antibiotics, and the central nervous system. For medical devices, it seeks to invest in early-stage companies focusing on novel, next generation devices to treat major, chronic diseases, diseases of aging, significant unmet medical needs in a variety of disease categories and therapeutic indications, including cardiovascular disease, central nervous system diseases, and aesthetic medicine. Within diagnostics, the firm also invests in implantable sensors that provide real-time health information that regulate therapeutics and development of personalized medicines and monitoring for various disease states, such as cancer, asthma, and diabetes. The firm seeks to invest in consumer internet and digital media; mobile; and enterprise and managed services in India. In Israel, the firm seeks investments in consumer internet and digital media, communications infrastructure, enterprise, clean tech, and medical device technologies. It seeks to invest globally with a focus on Asia, Israel, and United States. The firm typically invests between $1 million to $20 million in its portfolio company. Canaan Partners was founded in 1987 and is based in Menlo Park, California with additional offices in Westport, Connecticut; Herzliya Pituach, Israel; New York, New York; and Gurgaon, India.

Key Executives for Canaan Partners

Similar Private Companies By Industry

Recent Private Companies Transactions